An international consortium from the TU Dresden and the Helmholtz Zentrum München, together with researchers from Vienna, Bristol and Denver (USA) have successfully completed the first step in development of an insulin vaccine to prevent type 1 diabetes. As reported by the team in the journal JAMA, evaluations of the international Pre-POINT study point to a positive immune response in persons at risk for the … Continue reading Researchers complete the first human trials for insulin vaccine to prevent T1 diabetes.